Cargando…
Insertion of the protective APP A673T mutation by CRISPR/Cas9 base editing or PRIME editing.
There is currently no treatment for Alzheimer disease (AD). However, the Icelandic mutation in the APP gene (A673T) has been shown to confer a protection against the onset and development of AD (Jonsson et al. Nature 2012). This single nucleotide mutation in APP exon 16 reduces the cleavage of the A...
Autores principales: | Tremblay, Jacques, Guyon, Antoine, Rousseau, Joël, Tremblay, Guillaume, Begin, Francis-Gabriel, Lamothe, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681611/ http://dx.doi.org/10.1093/geroni/igab046.2511 |
Ejemplares similares
-
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro
por: Guyon, Antoine, et al.
Publicado: (2021) -
The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer’s Disease in SH-SY5Y cells
por: Guyon, Antoine, et al.
Publicado: (2020) -
Prime editing strategies to mediate exon skipping in DMD gene
por: Happi Mbakam, Cedric, et al.
Publicado: (2023) -
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy
por: Happi Mbakam, Cédric, et al.
Publicado: (2022) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)